Picture of Biotika as logo

1BSL01AE — Biotika as Share Price

0.000.00%
sk flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Momentum

Relative Strength (%)
1m+7.37%
3m+7.17%
6m+13.1%
1yr+14.66%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital3.25%
Return on Equity3.93%
Operating Margin8.26%

Financial Summary

Year End 31st DecUnit201620172018201920202021E2022ECAGR / Avg
Total Revenue€m24.3123.9926.0119.9317.65n/an/a-14.39%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-78.69-94.49+2309.53+63.39+14.77n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202131st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2021 / 2022

Blurred out image of Biotika as EPS forecast chart

Profile Summary

Biotika as is a Slovakia-based joint stock company that specializes in biotechnology and production of pharmaceutical. The Company's activities are grouped into three main areas: biotechnological production of the substances of penicillin, chlorotetracycline and dextrans; production of final drug-forms for both human and veterinary use, including: penicillin and cephalosporin preparations, hormonal preparations, vitamin preparations; as well as production of premixes containing nutrition additives and medicated nutritive preparations. As of December 31, 2011, the Company operated two wholly owned subsidiaries, COV as Slovenska Lupca and Biotkika KLF as Slovenska Lupca.

Directors

Last Annual
December 31st, 2020
Last Interim
June 30th, 2021
Incorporated
May 1st, 1992
Public Since
November 19th, 1993
No. of Employees
224
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
sk flag iconBratislava Stock Exchange
Shares in Issue
700,000
Blurred out image of a map
Address
Slovenska Lupca 566, SLOVENSKA LUPCA, 976 13
Web
http://www.biotika.sk
Phone
+421 484368111
Auditors
BDR, spol. s r.o. Banska Bystrica

1BSL01AE Share Price Performance

Upcoming Events for 1BSL01AE

Similar to 1BSL01AE

Picture of Zentiva as logo

Zentiva as

sk flag iconBratislava Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email